Stockreport

Jazz Pharmaceuticals (JAZZ) Is Up 5.1% After Monetizing FDA Voucher And Expanding Oncology Collaboration [Yahoo! Finance]

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com
PDF antibody zanidatamab in HER2-positive breast cancer within Boehringer's ongoing Beamion-BCGC1 trial. Around the same time, Jazz also sold a US$200,000,000 FDA priority [Read more]